Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: twentyfirstcenturyfox who wrote (14076)	12/29/2006 12:50:06 PM
From: Cal Gary	Read Replies (2) \| Respond to of 14101

Hi Joe and Don, Happy New Years. 171mm shares, new management, new company name and three FDA submissions later ... WOW. There's still this hurdle: In its letter, the FDA indicated that Pennsaid is approvable subject to Nuvo satisfying certain conditions. The company plans to meet with the FDA early in 2007 to discuss the letter. But is this a common standard feature of an Approvable letter? Or is there truly and something left to fix?? Glad to see the NR and hope to chat again.